Vertex Ventures: Investment Portfolio & Startup News
Vertex Ventures
To add a bio or update investment portfolio click update information.
Investment Portfolio


Metaview unlocks a £45m Series C led by Insight Partners to automate hiring with sourcing and screening agents
Metaview is a recruiting platform that deploys AI agents to source candidates, review applications, run structured screening conversations and turn interviews into usable notes. Hiring teams hand over the manual work of recruiting while people set the criteria and make every final decision.


Olix unlocks £160m in funding led by Hummingbird Ventures to launch chips designed to run trained AI models
Olix develops optical AI inference chips designed to run trained models more efficiently than traditional GPU-based systems. Its hardware focuses on reducing compute cost and energy use for inference workloads.


Metaview raises £25m Series B led by GV to scale its AI tools for hiring interviews
Metaview builds AI tools that capture and analyse job interviews, turning conversations into structured hiring intelligence that helps teams make more consistent, evidence-based recruitment decisions.


Bain Capital Ventures leads £18m Series A in Northflank revolutionising app and database deployments
Northflank offers a cloud platform that lets developers deploy, scale and manage applications and databases across any cloud provider, replacing fragmented infrastructure tools with a unified self-service environment.
- 2(12 months)
- vvus.com
More venture news
- 17 Nov 2026

Isomorphic LabsIsomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
Series CLife Sciences - 11 Nov 2026

FractileFractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
Series CDeep Tech - 15 Oct 2026

OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences